The Asian Age

Cipla unveils drug in Germany

- — PTI

New Delhi: Pharmaceut­ical major Cipla on Monday launched its generic drug used for treatment of asthma and chronic obstructiv­e pulmonary disease in Germany and Sweden. While the drug Salmeterol/ Fluticason­e MDI will be sold under the Serroflo brand in Germany, it will be marketed as Salmeterol/ Fluticason­e Cipla in Sweden, Cipla stated. Commenting on the developmen­t, Cipla Europe head Frank Pieters said, “With Serroflo we offer in Germany and Sweden an alternativ­e which is effective and efficient and therefore brings many advantages.”

Newspapers in English

Newspapers from India